View in Other Languages

MMJ PhytoTech Ltd

ASX:MMJ ISIN:AU000000MMJ4

Phytotech Medical ASX:PYL

MMJ PhytoTech Limited (ASX:MMJ) is focused on becoming a large-scale cannabis producer, targeting direct supply to the growing Canadian medical and recreational markets which will have an estimated combined value of C$8-9 billion by 2024.

The Company controls operations across the entire medicinal cannabis value chain through its ~60% interest in TSX-V listed Harvest One Cannabis Inc (CVE:HVST) and its 100% interest in Israeli research and development subsidiary, PhytoTech Therapeutics Ltd, both of which are strategically located in favourable jurisdictions with supportive regulatory frameworks in place.

       

News

MMJ PhytoTech Ltd (ASX:MMJ) Canada Set to Legalise Recreational Cannabis By July 2018

🕔3/29/2017 10:05:23 AM 2258

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that the Canadian Federal Government has confirmed it will move to legalise the recreational cannabis market by 1 July 2018. The Federal Government's initial plans and proposed legislative framework are expected to be publically released on 10 April 2017.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Australian Distribution Partner Receives Medicinal Cannabis Import Licence

🕔3/29/2017 9:48:26 AM 3954

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that the Company's Australian distribution partner, HL Pharma Pty Ltd, has received approval for a medicinal cannabis importation licence from the Department of Health.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Satipharm Sales Update and Expansion of European Distribution Network

🕔3/13/2017 8:24:40 AM 6393

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide the following sales and operations update on its wholly-owned Switzerland-based subsidiary, Satipharm AG.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Significantly Expands Duncon Facility Production Capacity with Land Lease Agreement

🕔3/9/2017 9:56:58 AM 4071

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that its wholly-owned subsidiary United Greeneries Holdings Ltd has executed an agreement with Cowichan Tribes in respect to the leasing of a 13-acre land package located adjacent to the Company's existing Duncan Facility.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Half-year Financial Report for Period Ended 31 December 2016

🕔3/1/2017 9:46:57 AM 2653

The directors present their report, together with the financial statements, on the consolidated entity consisting of MMJ PhytoTech Limited (ASX:MMJ) and the entities it controlled at the end of, or during, the half-year ended 31 December 2016.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Takes Significant Step Towards First Australian Sales Following Submission of Import Licence Application

🕔2/28/2017 9:29:05 AM 3609

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that the Company's Australian distribution partner, HL Pharma Pty Ltd. has submitted its application for a medicinal cannabis import licence to the Department of Health.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Announces Harvest One Closes C$25M Placement

🕔2/23/2017 9:28:36 AM 3124

MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that Canadian-based Harvest One Capital Corp. (CVE:WON.H) has closed the previously reported (January 27, 2017) private placement, raising C$25,000,500 before costs. Pursuant to the Placement, Harvest One issued 33,334,000 Subscription Receipts at a price of C$0.75.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Enters Agreement to Strengthen AUS Distribution Network

🕔2/13/2017 10:07:44 AM 3279

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that it has entered into a binding Letter of Intent with HL Pharma Pty Ltd. for the importation and distribution of the Company's medicinal cannabis products in Australia.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Phase 2 Clinical Trial For Treatment of Epilepsy Underway

🕔2/13/2017 8:23:49 AM 2587

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that its wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Limited ("PTL"), has commenced following Health Authorities' approval, the Phase 2 clinical study into the safety and efficacy of its PTL101 capsules in treating refractory epilepsy in children.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Quarterly Update

🕔2/1/2017 9:31:02 AM 3618

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide its quarterly activities report for the period ended 31 December 2016.

Read Full Article
###

39,653 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 213) (Last 30 Days: 822) (Since Published: 28964) 

Markets ASX:MMJ

Company Data

    Headquarters
  • Suite 25, 145 Stirling Highway
    Nedlands WA 6009
    Australia
  • Telephone
  • +61-8-9389-3150 
  • Fax
  • +61-8-9389-3199 
  • Principal Sector
  • Ag Biotechnology 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.mmjphytotech.com.au
  • E:
  • info@mmjphytotech.com.au

Presentations

Research Report

Quarterly Report

Social Media